Brief: Genscript Biotech Announces Deconsolidation Of Legend Biotech Corp And Its Subsidiaries
Oct 22 (Reuters) - Genscript Biotech Corp 1548.HK :
* VARIATION OF DEPOSIT AGREEMENT RESULTING IN
DECONSOLIDATION OF
LEGEND BIOTECH CORPORATION AND ITS SUBSIDIARIES
* EXPECTS DECONSOLIDATION TO HAVE SIGNIFICANT IMPACT ON
CONSOLIDATED FINANCIAL STATEMENTS OF GROUP FOR FY2024
* EXPECTED SIGNIFICANT AMOUNT OF GAIN WILL BE RECOGNIZED
UPON
DECONSOLIDATION
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale